Frequent migraines? New prevention studies may help guide choices
New migraine-prevention research adds to the evidence that some people do better with CGRP-targeting medicines, onabotulinumtoxinA, or older oral options. But the best choice still depends on migraine pattern, side effects, cost, and other health conditions.
If you get migraine attacks often, prevention may matter as much as treating pain once it starts. New studies are adding detail, but they do not create one best choice for everyone.
The main takeaway is simple: preventive treatment can be worth discussing when migraines are frequent, hard to stop, or disrupting work, school, or family life. The right option depends on your migraine pattern, your other health conditions, and how well you can tolerate a medicine.
What the new studies suggest
Recent research continues to support several prevention approaches for selected patients. That includes CGRP-targeting medicines, onabotulinumtoxinA for chronic migraine, and some oral preventive drugs.
One recent randomized trial found that benefits with eptinezumab were maintained over long-term treatment for many participants. Another real-world study in adults age 65 and older found galcanezumab was effective and generally well tolerated in that group.
What the candesartan study adds
A comparative cohort study reported better tolerability and effectiveness with candesartan than with topiramate in a real-world headache clinic population. That is useful, but it is not the same as proving candesartan is better for everyone.
Because this was a cohort study, the patients were not randomly assigned in the same way they would be in a randomized trial. That means differences between groups, even after adjustment, can still affect the result.
What the evidence cannot prove
These newer studies help fill gaps, but they do not settle every question. Migraine prevention research still has limits, including differences in who gets enrolled, how long people are followed, and whether the study reflects everyday U.S. practice.
That matters because migraine is not one condition with one treatment path. People with episodic migraine may need different options than people with chronic migraine. Older adults, people with heart disease, and people who have already tried several preventives may also need a different risk-benefit discussion.
How to think about choosing a preventive
For many people, the decision comes down to a few practical issues:
- Side effects: Some migraine preventives can cause sleepiness, brain fog, tingling, weight changes, constipation, or other problems that affect day-to-day use.
- Access and cost: Injectable and infusion-based medicines can face prior authorization, higher copays, or specialty-pharmacy requirements.
- Health conditions: Your blood pressure, kidney health, cardiovascular history, and other medicines can shape the safest option.
- Migraine type: Chronic migraine and high-frequency episodic migraine may be treated differently than infrequent attacks.
MedlinePlus notes that prevention is usually considered when migraines are frequent or severe, and that people should discuss the best drug option with a clinician. The FDA also reminds patients and clinicians that prescription medicines should be monitored for safety after they are started.
When to talk to a clinician
It may be time to ask about prevention if you have headaches that are becoming more frequent, if your acute medicines are not working well enough, or if you are using pain medicine so often that rebound headaches are a concern.
Get urgent medical care if you have a sudden, severe headache unlike your usual migraine, a headache after head injury, fever with a stiff neck, new weakness or confusion, trouble speaking, vision loss, or a headache with other stroke-like symptoms.
Bottom line
Prevention is worth discussing when migraines are frequent or disabling. The latest studies add options and context, but the best preventive still depends on the individual.
If you are weighing choices, bring a simple headache log to your next visit: how often attacks happen, how long they last, what medicines you use, and what side effects you have noticed.
Sources
Editorial note: Weence articles are researched from cited public-health, medical, regulatory, journal, and reputable news sources and may be drafted with AI assistance. They are checked for source support, clarity, and safety guardrails before publication.
This article is for general informational purposes only and is not medical advice. Research findings can be early or incomplete, and health guidance can change. Always talk with a qualified healthcare professional about personal symptoms, diagnosis, medications, vaccines, screenings, or treatment decisions. If you think you may have a medical emergency, call emergency services right away.
